[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4916 followers
Created: 2025-07-18 11:55:07 UTC

Quo vadis, #NovoNordisk? Current analyst estimates imply sales growth of around XX% and operating profit growth of around XX% - P/E XX for '25 and XX for '26.
Despite all the headwinds, even if Novo Nordisk cancels the upper end of its forecast, estimates are unlikely to fall any further. Good risk/reward ratio here imo. $NVO $NOVOB $LLY

![](https://pbs.twimg.com/media/GwIzgt2WQAE0SN0.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946176905088057607/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[$novob](/topic/$novob)
[$novcde](/topic/$novcde)
[novo](/topic/novo)
[quo](/topic/quo)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)

[Post Link](https://x.com/doepke_michel/status/1946176905088057607)